Search results
Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead
Investing.com via Yahoo Finance· 2 weeks agoAurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA ...
Pharma, IT stocks lift Indian shares at the start of data-heavy week
Reuters via Yahoo Finance· 10 months agoBENGALURU (Reuters) -Indian shares rose on Monday, helped by pharma and information technology (IT)...
India's Aurobindo Pharma misses Q3 profit view on higher input costs
Reuters via Yahoo Finance· 1 year agoBENGALURU (Reuters) - India's Aurobindo Pharma Ltd reported third-quarter profit that missed analysts' estimates on Thursday, as higher input costs offset strong sales in its key United States ...
Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug
Benzinga via Yahoo Finance· 1 year agoViiV Healthcare and Medicines Patent Pool (MPP) have signed sublicence agreements with Aurobindo...
Indian shares log second weekly gain on energy stocks boost
Reuters via Yahoo Finance· 7 months agoBy Bharath Rajeswaran BENGALURU (Reuters) -Indian shares rose for a second consecutive week on...
Analysis-Novartis CEO may struggle to rally investors to Sandoz spin-off
Reuters via Yahoo Finance· 2 years agoNovartis CEO Vas Narasimhan could struggle to woo investors to the listing of generics drugs...
Here's Why You Should Add Dr. Reddy's (RDY) to Your Portfolio
Zacks via Yahoo Finance· 10 months agoDr. Reddy's (RDY) continues to enjoy a strong foothold in the global generics market due to its deep...
ADHD drug shortage shows signs of letting up, but some patients still struggle
NBC News via Yahoo News· 3 weeks agoADHD medication shortages have largely been resolved, says the FDA. However, some doctors and...
Novartis to spin off generics business Sandoz next year
Reuters via Yahoo Finance· 2 years agoZURICH/LONDON (Reuters) -Novartis plans to spin off its underperforming generics unit Sandoz to...
India's mid and small cap stocks risk abrupt corrections, warn analysts
Reuters via Yahoo Finance· 12 months agoA roaring rally in mid- and small-cap stocks listed on Indian bourses could see abrupt corrections,...